Related Experiment Video
Updated: Jul 15, 2026

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence
Published on: March 1, 2024
The anti-thrombotic active constituents from Centella asiatica
Toshiko Satake1, Kohei Kamiya, Yin An
1Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan.
Centella asiatica methanol extract impacts platelet activation. 3,5-di-O-caffeoyl quinic acid specifically inhibited shear-induced platelet activation and dynamic coagulation in rats.
Area of Science:
- Pharmacology
- Natural Products Chemistry
Background:
- Centella asiatica is a medicinal plant with various reported bioactivities.
- Platelet activation and coagulation are critical in hemostasis and thrombosis.
- Understanding natural compounds' effects on these processes is vital for therapeutic development.
Purpose of the Study:
- To investigate the in vitro effects of a Centella asiatica methanol extract on shear-induced platelet activation and coagulation.
- To identify active compounds within the extract responsible for these effects.
Main Methods:
- Oral administration of Centella asiatica methanol extract to rats.
- Assessment of platelet activation and coagulation using haemostatometry on non-anticoagulated blood.
- Isolation and identification of chemical constituents from the extract.
Main Results:
- The methanol extract of Centella asiatica was found to affect platelet activation and coagulation.
- Several compounds were isolated, including chlorogenic acid, asiaticoside, kaempferol, quercetin, and various di-O-caffeoyl quinic acids.
- 3,5-di-O-caffeoyl quinic acid demonstrated significant inhibition of shear-induced platelet activation and dynamic coagulation.
- The inhibitory effect exhibited a bell-shaped reactive curve.
Conclusions:
- 3,5-di-O-caffeoyl quinic acid is a key active component in Centella asiatica extract responsible for inhibiting platelet activation and coagulation.
- This finding supports the traditional use of Centella asiatica and suggests potential applications in managing thrombotic disorders.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
